{"public_id":"co_0e671cd4c282b5b1a18e3e812f4dc97b","status":"active","merged_into_public_id":null,"resolved_public_id":"co_0e671cd4c282b5b1a18e3e812f4dc97b","name":"FA-DOX-BSA MNPs","description":"A targeted nanodrug combining folic acid, doxorubicin, and magnetic iron oxide encapsulated in bovine serum albumin nanospheres for combined chemotherapy, hyperthermia, and folate-receptor targeting.","aliases":["folic acid-conjugated, doxorubicin-loaded, magnetic iron oxide bovine serum albumin nanospheres"],"types":["nanomaterial","drug delivery system"],"contributors":[{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["extraction"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":7513373,"title":"Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo","citation_count":68,"url":"https://sah.borca.ai/papers/7513373"}],"claims":[{"public_id":"cl_231ab6cabb4cbb1e82ac4bc545045a10","text":"FA-DOX-BSA MNPs are prepared using a desolvation cross-linking method, with activated folic acid conjugated to the albumin nanosphere surface via amino groups.","corpus_id":7513373,"url":"https://sah.borca.ai/claims/cl_231ab6cabb4cbb1e82ac4bc545045a10"},{"public_id":"cl_53ed6ed525427ce7a9e427e166f6fe8f","text":"The nanospheres deliver doxorubicin at clinically relevant doses with an entrapment efficiency of 80%.","corpus_id":7513373,"url":"https://sah.borca.ai/claims/cl_53ed6ed525427ce7a9e427e166f6fe8f"},{"public_id":"cl_75551f93e72932a6042aec6ff8f5412d","text":"FA-DOX-BSA MNPs show greater inhibition of nasopharyngeal carcinoma tumors than nanospheres lacking folic acid, both in vitro and in vivo.","corpus_id":7513373,"url":"https://sah.borca.ai/claims/cl_75551f93e72932a6042aec6ff8f5412d"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_0e671cd4c282b5b1a18e3e812f4dc97b","url":"https://sah.borca.ai/concepts/co_0e671cd4c282b5b1a18e3e812f4dc97b"}